Fujun Wang

LncRNA MALAT1 induces the dysfunction of β cells via reducing the histone acetylation of the PDX-1 promoter in type 1 diabetes

Haixia Ding, Fujun Wang, Xuelian Shi et al. · Experimental and Molecular Pathology · 2020 · 67 citations

Lncrna Malat1, Type 1, Transcriptional Regulation +14

CCL5 secreted by tumor associated macrophages may be a new target in treatment of gastric cancer

Haixia Ding, Lianmei Zhao, Suli Dai et al. · Biomedicine & Pharmacotherapy · 2015 · 62 citations

Tumor Biology, Gastrointestinal Oncology, Immunology +8

Membrane Fusion‐Mediated Loading of Therapeutic siRNA into Exosome for Tissue‐Specific Application

Miao Xie, Yuqing Wu, Yilun Zhang et al. · Advanced Materials · 2024 · 58 citations

Engineering, Tissue‐specific Application, Therapeutic Sirna +19

A novel human derived cell-penetrating peptide in drug delivery

Jian Zhao, Peng Gao, Wei Xiao et al. · Molecular Biology Reports · 2010 · 23 citations

Cell-based Drug Delivery, Nanomedicine, Engineering +5

Claudin18.2 as a potential therapeutic target for primary ovarian mucinous carcinomas and metastatic ovarian mucinous carcinomas from upper gastrointestinal primary tumours

Fujun Wang, Yao Yang, Xiuzhen Du et al. · BMC Cancer · 2023 · 16 citations · Full text